Farringdon Capital Ltd. Buys New Stake in Stryker Co. (NYSE:SYK)

Farringdon Capital Ltd. bought a new position in shares of Stryker Co. (NYSE:SYK - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 1,794 shares of the medical technology company's stock, valued at approximately $646,000.

A number of other institutional investors have also added to or reduced their stakes in SYK. NewEdge Advisors LLC lifted its holdings in Stryker by 16.4% during the fourth quarter. NewEdge Advisors LLC now owns 27,487 shares of the medical technology company's stock worth $9,897,000 after buying an additional 3,873 shares during the period. Gamco Investors INC. ET AL grew its stake in Stryker by 17.1% in the fourth quarter. Gamco Investors INC. ET AL now owns 21,568 shares of the medical technology company's stock valued at $7,766,000 after purchasing an additional 3,150 shares during the last quarter. Jump Financial LLC purchased a new position in Stryker during the 4th quarter worth $4,204,000. Kane Investment Management Inc. purchased a new stake in Stryker in the fourth quarter valued at about $749,000. Finally, Guggenheim Capital LLC boosted its stake in Stryker by 7.0% in the 4th quarter. Guggenheim Capital LLC now owns 7,579 shares of the medical technology company's stock worth $2,729,000 after purchasing an additional 499 shares in the last quarter. Hedge funds and other institutional investors own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on SYK shares. BTIG Research set a $403.00 price target on Stryker and gave the stock a "buy" rating in a research report on Monday, April 14th. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a report on Tuesday, February 18th. Needham & Company LLC reissued a "buy" rating and set a $442.00 target price on shares of Stryker in a report on Friday, March 21st. Truist Financial upped their price target on shares of Stryker from $409.00 to $413.00 and gave the company a "hold" rating in a report on Thursday, January 30th. Finally, StockNews.com downgraded shares of Stryker from a "buy" rating to a "hold" rating in a research note on Thursday, March 6th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $423.53.

Insider Buying and Selling at Stryker

In related news, Director Allan C. Golston sold 2,458 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the sale, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. This represents a 14.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the business's stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares of the company's stock, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Stryker Trading Up 2.3 %

Shares of NYSE:SYK traded up $7.74 during mid-day trading on Tuesday, reaching $347.33. 366,620 shares of the company were exchanged, compared to its average volume of 1,587,879. The firm has a market cap of $132.57 billion, a price-to-earnings ratio of 44.76, a P/E/G ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The firm's 50-day simple moving average is $370.04 and its 200 day simple moving average is $373.23.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the business posted $3.46 EPS. Equities research analysts forecast that Stryker Co. will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be issued a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.97%. Stryker's dividend payout ratio (DPR) is presently 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.